1140 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORSE. Barnes,A. Folgori,S. Capone,S. Aston,J. Meyer,K. Gantlett,K.E. Smith,R. Huddart,A.C. Brown,A. Kurioka,I. Humphreys,G.L.A. Harrison,C. Kelly,V. Ammendola,S. Colloca,M. Naddeo,L. Siani,C. Traboni,R. Córtese,A. Nicosia,P. KlenermanJournal of Hepatology（2011）引用 0|浏览31暂无评分关键词adenoviral vectorAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
